Landmark legislation in Italy: Provisions for the treatment of rare diseases and for the support of research and production of orphan drugs
FDA approves first drug to improve growth in children with most common form of Dwarfism
NICE creates new menu of treatment options for those suffering from depression
Safety signals have sparked vital discussions on patient access to ATMPs, marking a pivotal moment i...
We discuss the 2024 VPAG agreement, how it differs from the previous VPAS and whether this will impa...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Δ
